MOL PLUS has decided to invest in Pyxis Maritime, a Singapore-based developer of electric vessels and operator of electric ...

The initial funding round underscores growing investor confidence in decarbonising regional port and shipping operations. SINGAPORE - Media OutReach Newswire - 22 December 2025 - Pyxis, a leading ...

Pyxis secured S$13 million in the first close of its S$18 million growth funding round, reflecting strong investor confidence in its vessel technology, commercial traction, and regional growth ...

The latest firmware from Blackmagic has added pre-recording on two of its physical camera models. the URSA Broadcast G2 , the PYXIS 6K and 12K. (Ahead I’ll clarify the differences between ...

Pyxis Oncology Inc. (NASDAQ: PYXS) on Thursday released preliminary data from its ongoing Phase 1 studies of micvotabart pelidotin (MICVO) for recurrent/metastatic head and neck squamous cell ...

Investing.com - H.C. Wainwright raised its price target on Pyxis Oncology Inc. (NASDAQ:PYXS) to $7.00 from $5.00 on Friday, while maintaining a Buy rating on the stock. This target represents ...

Shares of Pyxis Oncology dropped after the pharmaceutical company said data from its trials on a treatment for a form of head and neck cancer showed a high incidence of adverse effects. The stock fell ...

Investing.com -- Pyxis Oncology Inc (NASDAQ:PYXS) stock tumbled 49.9% in premarket trading Thursday after investors expressed disappointment with preliminary data from the company’s experimental ...

46% confirmed objective response rate (ORR) and 92% disease control rate (DCR) observed with MICVO as monotherapy in 2L+ R/M HNSCC at 5.4 mg/kg 71% confirmed ORR and 100% DCR observed with MICVO in ...